Latest Headlines

  1. New AI Solution From Catalyx Slashes Line Clearance Time And Boosts Manufacturing Efficiency 2/10/2026

    With production bottlenecks costing life sciences manufacturers millions in lost productivity, Catalyx today unveiled OpenLine LineClearance Assistant™ 3.0, a breakthrough AI-powered solution addressing this issue. The new solution transforms line clearance into a fully automated digital process, accelerating product changeover time, minimizing downtime, and maximizing operational efficiency.

  2. AsymBio Establishes Integrated Technology Platforms Spanning The Full Biopharmaceutical Development Lifecycle 2/10/2026

    AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning the full biopharmaceutical development lifecycle. Through its end-to-end service capabilities, the company provides streamlined, integrated workflows from early development to commercial manufacturing.

  3. KeyPlants AB Expands Production Capacity With New Facility In Götene, Sweden 2/9/2026

    KeyPlants AB is strengthening its global production capacity through a significant expansion into Götene, Sweden. In response to a recently secured large-scale order and an increasingly strong project pipeline, the company is establishing operations at the Götenehus industrial site under a four-year lease agreement with Forshem Fastigheter.

  4. Is A Cybersecurity Boom On The Horizon? KPMG Survey Shows Surge In Cybersecurity Investment As AI Threats Redefine Risk 2/5/2026

    A cybersecurity boom appears imminent as businesses invest to defend against a new generation of sophisticated, AI-driven threats. According to the 2025 KPMG Cybersecurity Survey, a staggering 99% of security leaders plan to increase their cybersecurity budgets over the next two to three years, signaling that cybersecurity is no longer just a priority but a critical business imperative.

  5. Eli Lilly To Build New $3.5B Injectable Drug Manufacturing Site Supporting GLP-1 Therapies In Pennsylvania 2/2/2026

    Eli Lilly and Company (NYSE: LLY) today announced plans to invest more than $3.5 billion in a new manufacturing facility in the Lehigh Valley, Pennsylvania.

  6. Veranova Appoints Jacquelyn Martin As Chief Quality Officer 1/28/2026
  7. Halo Pharma To Become A Stand-Alone Drug Product Contract Development And Manufacturing Organization (CDMO) 1/27/2026

    Halo Pharma, a leading CDMO specializing in drug product pharmaceutical development and manufacturing services, will become a stand-alone business as a result of the sale of the Noramco API and associated businesses to Siegfried.

  8. Coating Place Announces Leadership Appointments To Support Next Phase Of Growth 1/23/2026

    As Coating Place celebrates its 50th anniversary, the company continues to build on its long-standing reputation as the industry leader in Wurster-based fluid bed technology for controlled release and taste masking applications.

  9. Mikart Celebrates 50 Years Of Excellence In Pharmaceutical Manufacturing 1/22/2026

    Mikart, a leading Contract Development and Manufacturing Organization (CDMO) specializing in small-molecule pharmaceutical products, proudly celebrates its 50th anniversary. Since its founding in 1975, Mikart has been dedicated to delivering innovative solutions, quality manufacturing, and outstanding service to its clients in the pharmaceutical industry.

  10. Mikart Signs Lease For New Headquarters At Cumberland Center II In Northwest Atlanta 1/22/2026

    Mikart, a leading contract development and manufacturing organization (CDMO), today announced that it has signed a lease for new headquarters space at the Cumberland Center II, a premier office tower in the Cumberland-Galleria region of Northwest Atlanta. The newly leased facility, encompassing approximately 13,000 square feet, will house Mikart’s administrative and corporate functions.